Related Experiment Video
Updated: May 9, 2026
A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
Published on: November 7, 2017
Calcific uremic arteriolopathy: overview for the nurse
1University of Pittsburgh Physicians, Department of Critical Care Medicine at University of Pittsburgh Medical Center, Presbyterian Campus, 200 Lothrop St., Pittsburgh, PA 15213, USA. andersonkg@upmc.edu
Insights
Calcific uremic arteriolopathy (CUA) is a rare condition affecting kidney disease patients. Early recognition and a multidisciplinary approach are crucial for managing this often fatal disease.
Area of Science:
- Nephrology
- Vascular Biology
- Dermatology
Background:
- Calcific uremic arteriolopathy (CUA) is an increasingly prevalent condition, primarily affecting patients with chronic kidney disease (CKD).
- CUA is particularly common in patients nearing end-stage renal disease (ESRD), undergoing dialysis, and with secondary hyperparathyroidism.
- The condition disproportionately affects women (3:1 ratio) with a median age at diagnosis of 48 years.
Observation:
- The pathogenesis of CUA is not well understood, and definitive treatment plans are lacking.
- Clinical presentation of CUA requires familiarity among healthcare professionals for early recognition.
- Nurses play a vital role in patient comfort, dignity, and setting realistic goals of care.
Findings:
- Despite its rarity, CUA is often fatal, underscoring the need for prompt diagnosis and intervention.
- Optimal management of CUA necessitates a multidisciplinary healthcare team approach.
- Early identification of CUA is critical for developing effective treatment strategies and preventing disease progression.
Implications:
- Increased awareness and understanding of CUA among healthcare providers, especially nurses, are essential.
- Further research into the pathogenesis of CUA is needed to develop targeted therapies.
- A collaborative, multidisciplinary approach is key to improving patient outcomes and managing CUA effectively.
Abstract:
Calcific uremic arteriolopathy is a little understood diagnosis of increasing prevalence seen predominantly in patients with chronic kidney disease, particularly those who are approaching end-stage renal disease, who are undergoing renal dialysis, and who have secondary hyperparathyroidism. Calcific uremic arteriolopathy affects women more frequently than men, at a ratio of 3:1, and the median age at diagnosis is 48 years. A clear understanding of the pathogenesis and definitive plans of care are lacking. Nurses should be familiar with the clinical picture of calcific uremic arteriolopathy. Early recognition is important to develop optimal treatment plans and to limit progression of this rare but often fatal disease. Nurses have a pivotal role in maintaining the patient's comfort and dignity, while setting realistic goals of care. Calcific uremic arteriolopathy remains a rare and complex clinical condition that requires a multidisciplinary health care team approach to provide the optimal level of care. Nurses have an essential role in the care of patients with the diagnosis of calcific uremic arteriolopathy.
Related Concept Videos
01:18Chronic Kidney Disease IV: Nursing Management
01:23Atherosclerosis IV: Nursing Management
01:20Acute Kidney Injury V: Interprofessional Care
01:24Chronic Kidney Disease II: Clinical Manifestations
01:24Nephrotic Syndrome III : Nursing Management
01:22Acute Kidney Injury VI: Nursing Management